Links to independent studies

Diagnostic Accuracy of a Bacterial and Viral Biomarker Point-of-Care Test in the Outpatient Setting

https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2797455

Economic Evaluation of FebriDx®

Economic Evaluation of FebriDx®: A Novel Rapid, Point-of-Care Test for Differentiation of Viral versus Bacterial Acute Respiratory Infection in the United States

https://jheor.org/article/27753-economic-evaluation-of-febridx-a-novel-rapid-point-of-care-test-for-differentiation-of-viral-versus-bacterial-acute-respiratory-infection-in-the-un

A prospective, multi-center US clinical trial to determine accuracy of FebriDx point-of-care testing

https://www.tandfonline.com/doi/full/10.1080/07853890.2018.1474002#abstract

Novel point-of-care biomarker combination tests to differentiate acute bacterial from viral respiratory tract infections to guide antibiotic prescribing: a systematic review

https://pubmed.ncbi.nlm.nih.gov/34015531/

FebriDx FDA 510(k) Premarket Notification

https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K230917

Links to independent studies

Diagnostic Accuracy of a Bacterial and Viral Biomarker Point-of-Care Test in the Outpatient Setting

Economic Evaluation of FebriDx®

A prospective, multi-center US clinical trial to determine accuracy of FebriDx point-of-care testing

Novel point-of-care biomarker combination tests to differentiate acute bacterial from viral respiratory tract infections to guide antibiotic prescribing: a systematic review

FebriDx FDA 510(k) Premarket Notification

our blog

This website uses cookies.